In a perfect world, the minister would not be in this position, and he might question the timeline

When he was announcing the PBS listing of one of these at-risk MS medicines late last year, having presumably been told that any price reduction would put it at risk, officials were probably well and truly in the process of manoeuvring the provider of another off-patent medicine brand into accepting an almost 50 per cent cut. …